Your shopping cart is currently empty

Galegine hydrochloride, a guanidine derivative derived from G. officinalis, plays a role in inducing weight loss in mice and has contributed to the development of biguanides, including metformin and phenformin. This compound stimulates AMPK activation in 3T3-L1 adipocytes, L6 myotubes, H4IIE rat hepatoma, and HEK293 human kidney cell lines. Additionally, galegine hydrochloride exhibits antibacterial properties, particularly demonstrating a minimum inhibitory concentration of 4 mg/L against Staphylococcus aureus strains[1][2].

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 25 mg | Inquiry | 6-8 weeks | 6-8 weeks | |
| 50 mg | Inquiry | 6-8 weeks | 6-8 weeks | |
| 100 mg | Inquiry | 6-8 weeks | 6-8 weeks |
| Description | Galegine hydrochloride, a guanidine derivative derived from G. officinalis, plays a role in inducing weight loss in mice and has contributed to the development of biguanides, including metformin and phenformin. This compound stimulates AMPK activation in 3T3-L1 adipocytes, L6 myotubes, H4IIE rat hepatoma, and HEK293 human kidney cell lines. Additionally, galegine hydrochloride exhibits antibacterial properties, particularly demonstrating a minimum inhibitory concentration of 4 mg/L against Staphylococcus aureus strains[1][2]. |
| In vitro | Pre-treatment with Galegine hydrochloride (10 μM-3 mM; 5 h) enhances insulin-independent glucose absorption in 3T3-L1 adipocytes concentration-dependently, without impacting cell health. Similarly, incubation (1 μM-1 mM, 5 h) boosts glucose intake in L6 myotubes without affecting viability[1]. Galegine hydrochloride (0.3-300 μM; 24 hours) slightly decreases basal glycerol release and significantly reduces isoprenaline-induced glycerol release in 3T3-L1 adipocytes. In H4IIE rat hepatoma cells, Galegine hydrochloride (10 or 300 μM) up to 6 hours progressively activates AMPK, reaching peak activation at 360 min and maintaining twofold activation at 24 hours with 300 μM, showing a stronger effect at 300 μM than at 10 μM. A one-hour incubation triggers concentration-dependent AMPK activation in both 3T3L-1 adipocytes and L-6 myotubes, as well as in a human kidney cell line (HEK293)[1]. |
| In vivo | Galegine hydrochloride (63 mg/kg; feed; daily for 11 days) significantly reduces body weight[1]. |
| Molecular Weight | 163.65 |
| Formula | C6H14ClN3 |
| Cas No. | 2368870-39-5 |
| Smiles | Cl.CC(C)=CCNC(N)=N |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | ||||||||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 5.2 mg/mL (31.78 mM), Sonication is recommended. H2O: 43.33 mg/mL (264.77 mM), Sonication is recommended. | ||||||||||||||||||||||||||||||||||||||||
Solution Preparation Table | |||||||||||||||||||||||||||||||||||||||||
DMSO/H2O
H2O
| |||||||||||||||||||||||||||||||||||||||||
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.